What is she best known for?
The fields of study she is best known for:
- Dopamine
- Internal medicine
- Neurotransmitter
Athina Markou mostly deals with Pharmacology, Nicotine, Brain stimulation reward, Self-administration and Neuroscience.
Her Pharmacology study combines topics in areas such as Glutamate receptor, Metabotropic glutamate receptor 5, Dopamine and Nicotinic acetylcholine receptor.
The Glutamate receptor study combines topics in areas such as Ventral tegmental area and Neurotransmitter.
In general Nicotine, her work in Nicotine withdrawal is often linked to Complex variables linking many areas of study.
Her research in Brain stimulation reward intersects with topics in Drug withdrawal, Addiction and Anhedonia.
Her Neuroscience research includes themes of Animal model and Pharmaceutical industry.
Her most cited work include:
- Assessing antidepressant activity in rodents: recent developments and future needs (1326 citations)
- Neurobiological similarities in depression and drug dependence : A self-medication hypothesis (628 citations)
- Guidelines on nicotine dose selection for in vivo research (627 citations)
What are the main themes of her work throughout her whole career to date?
Her main research concerns Pharmacology, Nicotine, Brain stimulation reward, Neuroscience and Internal medicine.
Self-administration is the focus of her Pharmacology research.
Her study on Nicotine withdrawal is often connected to Alkaloid as part of broader study in Nicotine.
Her Brain stimulation reward research includes elements of Stimulation, Lateral hypothalamus, Addiction and Anhedonia.
Athina Markou has researched Neuroscience in several fields, including Methamphetamine and Prepulse inhibition.
Her Internal medicine research is multidisciplinary, relying on both Anesthesia, Endocrinology and Ethanol.
She most often published in these fields:
- Pharmacology (45.67%)
- Nicotine (42.13%)
- Brain stimulation reward (28.74%)
What were the highlights of her more recent work (between 2012-2018)?
- Nicotine (42.13%)
- Pharmacology (45.67%)
- Neuroscience (27.17%)
In recent papers she was focusing on the following fields of study:
The scientist’s investigation covers issues in Nicotine, Pharmacology, Neuroscience, Internal medicine and Endocrinology.
Her work carried out in the field of Nicotine brings together such families of science as Self-administration, Smoking cessation and Animal studies.
The concepts of her Self-administration study are interwoven with issues in Taste aversion and Addiction.
Her Pharmacology study incorporates themes from Glutamate receptor, GABAB receptor, Agonist, Metabotropic receptor and Allosteric regulation.
Her Internal medicine research incorporates elements of Ethanol, Anesthesia and Impulsivity.
Her Brain stimulation reward research is multidisciplinary, incorporating perspectives in Ventral tegmental area and Social defeat.
Between 2012 and 2018, her most popular works were:
- Enduring deficits in brain reward function after chronic social defeat in rats: susceptibility, resilience, and antidepressant response (94 citations)
- Measuring reinforcement learning and motivation constructs in experimental animals: relevance to the negative symptoms of schizophrenia. (72 citations)
- Association Between Nicotine Withdrawal and Reward Responsiveness in Humans and Rats (62 citations)
In her most recent research, the most cited papers focused on:
- Dopamine
- Internal medicine
- Neurotransmitter
Her scientific interests lie mostly in Nicotine, Pharmacology, Psychiatry, Glutamate receptor and Glutamatergic.
The study incorporates disciplines such as Self-administration and Abstinence in addition to Nicotine.
In her study, Internal medicine, Endocrinology and Analysis of variance is strongly linked to Delayed reward, which falls under the umbrella field of Self-administration.
Her Pharmacology study combines topics from a wide range of disciplines, such as Elevated plus maze, Baclofen and GABAB receptor.
Her work is dedicated to discovering how Glutamate receptor, Smoking cessation are connected with Neurotransmission and Nicotinic agonist and other disciplines.
Her Neurotransmission study integrates concerns from other disciplines, such as Dopamine and Brain stimulation reward.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
